用于治疗由重新向的瘤性疹病毒引起的质母细胞瘤的治疗性疫苗接种
Francesca Piaggio1, Chiara Riviera2, Francesco Alessandrini3
1IRCCS Ospedale Policlinico San Martino, Genoa, Italy francesca.piaggio@hsanmartino.it paolo.malatesta@unige.it.
Journal for immunotherapy of cancer
|January 16, 2026
概括
一种人工瘤病毒,R-115,通过延长存活时间和诱导免疫记忆,对质母细胞瘤治疗有希望. 这种疗法证明了对HER2阳性和混合瘤的疗效,表明作为疫苗接种策略的潜力.
科学领域:
- 瘤治疗性病毒疗法
- 免疫治疗是一种免疫疗法.
- 质母细胞瘤研究研究
背景情况:
- 质母细胞瘤是一种具有不良预后的侵袭性脑瘤.
- 目前的治疗方法受到耐药性和瘤异质性的限制.
- 免疫疗法和型病毒疗法提供了有前途的新策略.
研究的目的:
- 为了评估R-115的治疗疗效,一种工程化瘤性简单疹病毒.
- 在具有HER2异质性的免疫能力强的质母细胞瘤模型中评估R-115.
- 为了研究R-115诱导抗瘤免疫记忆的潜力.
主要方法:
- 研究R-115,一个重定位的瘤性简单疹病毒,准HER2并表达IL-12.
- 在HER2+/HER2-混合质母细胞瘤模型中评估整体存活率.
- 通过重新挑战小鼠用HER2-阴性细胞来评估抗瘤疫苗的效果.
- 分析了免疫细胞的增殖,激活和瘤细胞的减少.
主要成果:
- 在25%的小鼠中,R-115显著延长了生存时间和根除了瘤.
- 治疗疗效独立于瘤的组成和时间表.
- R-115诱导了长期的免疫记忆,消除了二次瘤.
- 观察到对HER2阴性细胞的免疫反应,这表明交叉呈现或表皮质传播.
结论:
- R-115是治疗质母细胞瘤的一个有前途的候选药物.
- 该病毒表现出直接的细胞毒性和免疫刺激作用.
- 需要对R-115进行进一步的临床研究.
更多相关视频
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.4K
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
22.0K
相关概念视频
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
01:30Cancer Vaccines
974
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
974
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K